A detailed history of Tillman Hartley LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tillman Hartley LLC holds 4,544 shares of ABBV stock, worth $786,793. This represents 0.28% of its overall portfolio holdings.

Number of Shares
4,544
Previous 4,637 2.01%
Holding current value
$786,793
Previous $719 Million 15.15%
% of portfolio
0.28%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $14,863 - $16,935
-93 Reduced 2.01%
4,544 $827 Million
Q3 2023

Oct 20, 2023

SELL
$133.59 - $154.65 $102,997 - $119,235
-771 Reduced 14.26%
4,637 $691 Million
Q4 2022

Feb 22, 2023

BUY
$138.31 - $165.87 $747,980 - $897,024
5,408 New
5,408 $874 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tillman Hartley LLC Portfolio

Follow Tillman Hartley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tillman Hartley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tillman Hartley LLC with notifications on news.